Dapirolizumab pegol
From Wikipedia, the free encyclopedia
| Monoclonal antibody | |
|---|---|
| Type | ? |
| Target | CD40 ligand |
| Identifiers | |
| CAS Number | |
| DrugBank | |
| UNII | |
Dapirolizumab pegol is "a polyethylene glycol conjugated anti-CD40L Fab fragment" developed by Biogen and UCB for systemic lupus erythematosus.[1][2][3]